全球皮肤切片检查市场

预计到 2030 年全球皮肤切片检查市场规模将达到 1.492 亿美元

2024 年全球皮肤切片检查市场规模估计为 1.169 亿美元，预计到 2030 年将达到 1.492 亿美元，在 2024-2030 年分析期内的复合年增长率为 4.1%。刮除活检是报告中分析的细分领域之一，预计其复合年增长率为 3.2%，到分析期结束时将达到 7540 万美元。在分析期内，穿刺切片检查部分的增长率估计为 5.3%。

美国市场规模估计为 3,190 万美元，中国市场预计复合年增长率为 7.4%

预计 2024 年美国皮肤切片检查市场价值将达到 3,190 万美元。作为世界第二大经济体，中国预计到 2030 年市场规模将达到 3,020 万美元，2024 年至 2030 年的复合年增长率为 7.4%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 1.8% 和 3.2%。在欧洲，德国的复合年增长率预计为 2.4%。

全球「皮肤切片检查」市场—主要趋势和驱动因素摘要

为什么皮肤切片检查成为皮肤病治疗的诊断基石？

皮肤切片检查为了解多种皮肤病（从良性肿瘤和发炎性疾病到自体免疫疾病和各种皮肤癌）提供了重要的见解，巩固了其作为现代皮肤病学关键诊断技术的地位。这可以透过多种方法来完成，包括刮取切片检查、穿刺切片检查、切除活检和切开切片检查，以收集皮肤组织进行组织病理学分析。切片检查是一种微创、快速且门诊的手术，使其实用且易于临床医生接受。全球皮肤癌（尤其是黑色素瘤、基底细胞癌和鳞状细胞癌）的发生率不断上升，使得早期准确的切片检查诊断成为医学上的必要。此外，干癣、湿疹、红斑狼疮和扁平苔癣等慢性皮肤病通常需要切片检查确认以调整治疗。在精准医疗时代，切片检查不仅可以用于诊断，还可以用于预后，从而实现生物标记的发现、基因分析和免疫组织化学分析。真菌性皮肤病、麻风病、皮肤结核病等感染疾病在流行地区也需要进行皮肤切片检查。它的效用超越了疾病类型、年龄层和医疗保健环境，皮肤切片检查对于及时和明确的皮肤病诊断和治疗计划至关重要。

科技进步如何提高皮肤切片检查程序的准确性和效率？

最近的技术创新已将皮肤切片检查从手动、视觉引导程序转变为数据丰富的诊断过程。高解析度皮肤镜和数位成像系统使皮肤科医生能够在进行切片检查之前更准确地识别可疑病变。机器人辅助穿刺切片检查工具和整合切片皮肤扫描仪提高了程序的一致性并减少了组织损伤。组织病理学工作流程也正在透过数位病理学平台进行升级，该平台使用人工智慧和机器学习来扫描、分类和解释组织样本，使其更加准确和快速。全幻灯片成像，加上云端基础的资料共用，可以实现对复杂病例的远端咨询和第二意见。另一方面，诸如黏性贴片切片检查（例如胶带剥离）等微创技术已引起人们的关注，尤其是在小儿科和美容皮肤科领域，因为它们可以无痛地收集表层细胞。目前，分子诊断检测和基因组定序已在切片检查样本上进行常规研究，揭示突变和免疫特征，有助于个人化治疗，特别是黑色素瘤和罕见的皮肤淋巴瘤。透过一次性无菌器械、内建麻醉剂和快速固定剂，切片检查套件的自动化简化了临床程序。这些进步不仅提高了诊断产量比率，也提高了患者的安全性、满意度和治疗效果。

皮肤切片检查在临床和公共卫生环境中发挥什么作用？

皮肤切片检查在世界各地的皮肤病诊所、肿瘤中心、病理实验室、学术机构和公共卫生计画中发挥着至关重要的作用。在先进的医疗保健系统中，切片检查是皮肤病理学工作流程中不可或缺的一部分，并指南皮肤癌和自体免疫疾病的治疗决策。在肿瘤学中，切片检查对于肿瘤分期、评估手术边缘和评估治疗结果至关重要。在免疫皮肤病学中，我们支持复杂水痘疾病、血管炎和结缔组织疾病的诊断。儿科皮肤科医生使用切片检查来区分儿童良性皮疹和早发性遗传综合症。在贫困和偏远地区，配备切片检查套件包的流动皮肤病科有助于筛检和诊断被忽视的热带疾病，如利利什曼原虫症和足菌肿。公共皮肤癌筛检宣传活动通常结合切片检查功能，以提供当天的诊断和分类。切片检查在新的皮肤病治疗的临床试验中也发挥着重要作用，可作为疗效的基准和治疗后基准。此外，皮肤切片检查是学术和药物研究的基础，为新生物製药、局部治疗药物和疫苗的开发提供资讯。从早期检测到精准肿瘤学再到治疗研究，其跨领域重要性凸显了其在现代医疗保健生态系统中的重要角色。

皮肤切片检查市场的成长受到多种因素的推动，这些因素反映了皮肤病的趋势、技术整合以及医疗保健管道的扩大。

成长要素是，由于人口老化、紫外线照射增加和生活方式的改变，全球皮肤癌（尤其是黑色素瘤）的发生率不断增加。随着人们意识的增强和积极的皮肤健康行为，皮肤科服务也同步增长，导致临床和美容皮肤切片检查数量增加。技术集成，特别是数位病理学、人工智慧辅助诊断和分子分析，正在扩大切片检查效用范围和效率，鼓励在整个医疗保健领域更广泛地采用。此外，门诊和流动皮肤病学服务的普及使得切片检查变得更加容易，从而刺激了医院外该程序的发展。自体免疫和发炎性皮肤病的快速增加，尤其是在年轻人和由于环境压力而导致的人群中，进一步增加了对组织病理学确认的需求。新兴国家不断增长的医疗支出和基础设施，加上减少未确诊癌症和被忽视的皮肤病负担的努力，正在推动亚太、拉丁美洲和非洲的市场成长。同时，监管部门对新切片检查工具和非侵入性采样技术的核准正在使产品系列多样化并减少程序障碍。疾病流行、诊断创新、医疗保健分散化和全球准入等相互交叉的趋势正在推动皮肤切片检查市场的强劲和持续成长。

部分

类型（刮取切片检查、穿刺切片检查、切开切片检查）、适应症（皮肤癌、光化性角化病、皮肤炎、其他适应症）、最终用户（医院和诊所、诊断实验室、其他最终用户）

受访企业范例（共34家）

• AccuTec Blades Inc.
• Acuderm Inc.
• Becton, Dickinson and Company
• Biodesix
• Biomarker Technologies
• Boston Scientific Corporation
• Cardinal Health
• Cook Medical
• Danaher Corporation
• DTR Medical Ltd
• Exact Sciences Corporation
• Freenome Holdings, Inc.
• Gallini Srl
• GenMark Diagnostics
• GRAIL, Inc.
• Hologic, Inc.
• Innovia Medical
• Integra LifeSciences
• Leica Biosystems
• Vernacare

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口（成品和OEM）预测公司竞争地位的变化。这种复杂且多方面的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、降低盈利、重组供应链等微观和宏观市场动态。

全球产业分析师密切关注世界领先的首席经济学家（14,949）、智库（62）和贸易及产业协会（171）的专家意见，以评估生态系统的影响并应对新的市场现实。各主要国家的专家和经济学家都在关注关税及其对国家的影响。

全球产业分析师预计，这种动盪将在未来几个月内平息，新的世界秩序将更加明确地建立。全球产业分析师正在即时追踪这些发展。

2025年4月：谈判阶段

我们四月份的发布将涵盖关税对全球市场整体的影响，并为各地区的市场调整提供指导。我们的预测是基于历史数据和不断发展的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将于 7 月收到免费更新。最终更新包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业和领域专家的最具影响力的首席经济学家，他们共用了全球经济状况这一前所未有的模式转移的影响。我们的 16,491 多份报告中的大多数都遵循这个基于两阶段里程碑的发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Skin Biopsy Market to Reach US$149.2 Million by 2030

The global market for Skin Biopsy estimated at US$116.9 Million in the year 2024, is expected to reach US$149.2 Million by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Shave Biopsy, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$75.4 Million by the end of the analysis period. Growth in the Punch Biopsy segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.9 Million While China is Forecast to Grow at 7.4% CAGR

The Skin Biopsy market in the U.S. is estimated at US$31.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$30.2 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global "Skin Biopsy" Market - Key Trends & Drivers Summarized

Why Has Skin Biopsy Become The Diagnostic Cornerstone Of Dermatological Care?

Skin biopsy has solidified its position as a primary diagnostic technique in modern dermatology, offering critical insights into a wide range of skin conditions, from benign growths and inflammatory disorders to autoimmune diseases and various forms of skin cancer. Performed using methods such as shave biopsy, punch biopsy, excisional biopsy, or incisional biopsy, the procedure allows for the extraction and histopathological analysis of skin tissue. It is minimally invasive, quick, and can be done in outpatient settings, making it a practical and accessible tool for clinicians. The rising global incidence of skin cancers-especially melanoma, basal cell carcinoma, and squamous cell carcinoma-has made early and accurate biopsy-driven diagnosis a medical necessity. Additionally, chronic dermatological conditions like psoriasis, eczema, lupus erythematosus, and lichen planus often require biopsy confirmation to tailor treatment. In the age of precision medicine, biopsies are not only diagnostic but also prognostic, enabling biomarker discovery, genetic analysis, and immunohistochemical profiling. Infections like fungal dermatoses, leprosy, and cutaneous tuberculosis also necessitate skin biopsies in endemic regions. With their utility spanning across disease types, age groups, and healthcare environments, skin biopsies are indispensable for timely, definitive dermatological diagnosis and treatment planning.

How Are Technological Advances Enhancing Accuracy And Efficiency In Skin Biopsy Procedures?

Recent technological innovations are transforming skin biopsy from a manual, visually guided procedure into a data-rich diagnostic process. High-resolution dermoscopy and digital imaging systems now allow dermatologists to identify suspicious lesions with greater precision before a biopsy is performed. Robotics-assisted punch biopsy tools and microtome-integrated skin scanners are improving procedural consistency and reducing tissue damage. Histopathology workflows have also been upgraded through digital pathology platforms that use AI and machine learning to scan, classify, and interpret tissue samples with enhanced accuracy and speed. Whole-slide imaging, coupled with cloud-based data sharing, allows for remote consultations and second opinions in complex cases. Meanwhile, minimally invasive techniques such as adhesive patch biopsies (e.g., tape stripping) are gaining attention for their ability to collect superficial cells painlessly, especially in pediatric and cosmetic dermatology. Molecular diagnostic assays and genomic sequencing are now routinely conducted on biopsy samples, revealing mutations and immune signatures that inform personalized treatment-especially in melanomas and rare cutaneous lymphomas. Automation in biopsy kits, including single-use sterilized instruments, built-in anesthetics, and rapid fixation solutions, is streamlining in-clinic procedures. Together, these advancements are not only enhancing diagnostic yield but also improving patient safety, satisfaction, and outcomes.

Where Is Skin Biopsy Playing A Transformative Role Across Clinical And Public Health Sectors?

Skin biopsy is playing a pivotal role across dermatology clinics, oncology centers, pathology labs, academic institutions, and public health programs worldwide. In developed healthcare systems, biopsies are integral to dermatopathology workflows, guiding treatment decisions in skin cancers and autoimmune conditions. In oncology, biopsies are essential for staging tumors, evaluating surgical margins, and assessing treatment response. In immunodermatology, they support the diagnosis of complex blistering diseases, vasculitis, and connective tissue disorders. Pediatric dermatologists rely on biopsies to distinguish between benign pediatric rashes and early-onset genetic syndromes. In underserved and remote areas, mobile dermatology units equipped with biopsy kits are helping screen and diagnose neglected tropical diseases, including leishmaniasis and mycetoma. Public skin cancer screening campaigns often integrate biopsy capabilities to provide same-day diagnosis and triage. Biopsies also play a critical role in clinical trials for new dermatological therapies, serving as baseline and post-treatment benchmarks for efficacy. Furthermore, skin biopsies are foundational in academic and pharmaceutical research, aiding in the development of new biologics, topical treatments, and vaccines. Their cross-disciplinary importance-from early detection to precision oncology and therapeutic research-highlights their indispensable role in modern healthcare ecosystems.

The Growth In The Skin Biopsy Market Is Driven By Several Factors That Reflect Dermatological Disease Trends, Technological Integration, And Healthcare Accessibility Expansion

A significant growth driver is the global rise in skin cancer incidence, especially melanoma, driven by aging populations, increased UV exposure, and lifestyle changes. Parallel growth in dermatology services, driven by improved awareness and proactive skin health behaviors, has led to a higher volume of skin biopsies in both clinical and cosmetic settings. Technological integration-particularly digital pathology, AI-assisted diagnostics, and molecular analysis-has expanded the scope and efficiency of biopsy utility, encouraging broader adoption across healthcare tiers. Additionally, the growing availability of dermatology services in ambulatory and outpatient settings has made biopsies more accessible, fueling procedural growth even outside of hospitals. The surge in autoimmune and inflammatory skin disorders, especially among younger demographics and due to environmental stressors, further amplifies the need for histopathological confirmation. Increasing healthcare spending and infrastructure in emerging economies, combined with efforts to reduce the burden of undiagnosed cancers and neglected skin conditions, are driving market growth in Asia-Pacific, Latin America, and Africa. Meanwhile, regulatory approval of newer biopsy tools and non-invasive sampling techniques is diversifying product portfolios and reducing procedural barriers. These intersecting trends-disease prevalence, diagnostic innovation, healthcare decentralization, and global access-are powering the strong, sustained expansion of the skin biopsy market.

SCOPE OF STUDY:

The report analyzes the Skin Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy); Indication (Skin Cancer, Actinic Keratosis, Dermatitis, Other Indications); End-Use (Hospitals & Clinics, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• AccuTec Blades Inc.
• Acuderm Inc.
• Becton, Dickinson and Company
• Biodesix
• Biomarker Technologies
• Boston Scientific Corporation
• Cardinal Health
• Cook Medical
• Danaher Corporation
• DTR Medical Ltd
• Exact Sciences Corporation
• Freenome Holdings, Inc.
• Gallini Srl
• GenMark Diagnostics
• GRAIL, Inc.
• Hologic, Inc.
• Innovia Medical
• Integra LifeSciences
• Leica Biosystems
• Vernacare

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Skin Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Skin Cancer and Chronic Dermatological Conditions Drives Biopsy Demand
  • Growing Awareness and Early Diagnosis Campaigns Propel Skin Biopsy Procedure Volume
  • Advancements in Minimally Invasive Biopsy Devices Improve Patient Acceptance and Outcomes
  • Increased Adoption of Teledermatology and AI Diagnostics Strengthens Screening Rates
  • Integration of Biopsy Services into Primary Care Clinics Expands Patient Access
  • Dermatology-Focused Clinical Trials and R&D Stimulate Market for Diagnostic Biopsies
  • Regulatory Approvals for New Biopsy Tools Accelerate Technology Penetration
  • Rising Demand for Histopathological Analysis in Aesthetic Dermatology Expands Market Scope
  • Expansion of Skin Biopsy Use in Personalized Medicine Drives Precision Diagnostics
  • Aging Population with Higher Incidence of Skin Disorders Sustains Long-Term Demand
  • Rapid Growth in Outpatient Dermatology Centers Spurs Procedural Volume
  • Health Insurance Coverage Expansion in Emerging Markets Improves Accessibility to Biopsy Services
  • Technological Improvements in Imaging-Guided Biopsies Enhance Diagnostic Accuracy
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Skin Biopsy Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Skin Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Shave Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Shave Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Shave Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Punch Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Punch Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Punch Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Excisional Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Excisional Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Excisional Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Skin Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Skin Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Skin Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Actinic Keratosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Actinic Keratosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Actinic Keratosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Dermatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• JAPAN
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• CHINA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• EUROPE
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Skin Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• FRANCE
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• GERMANY
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Skin Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• INDIA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Skin Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Skin Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• AFRICA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION